Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Diabetes|October 27, 2006
Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetesMaria Mastorikou, Mike Mackness, Bharti MacknessIUBMB Life|December 21, 2011
Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidationDavid Hine, Bharti Mackness, Mike MacknessArchives of Medical Science : AMS|March 22, 2013
Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart diseaseBharti Mackness, Wajdi Turkie, Mike MacknessBiochemical and Biophysical Research Communications|May 18, 2004
Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cellsBharti Mackness, David Hine, Yifen Liu, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndromeBharti Mackness, Rozenn Quarck, Wim Verreth, et al.Atherosclerosis|April 7, 2007
Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levelsWimon Phuntuwate, Chuthamanee Suthisisang, Banhan Koanantakul, et al.IUBMB Life|May 27, 2010
Human tissue distribution of paraoxonases 1 and 2 mRNABharti Mackness, Raul Beltran-Debon, Gerard Aragones, et al.Lancet (London, England)|March 13, 2002
Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dipNicola Cherry, Mike Mackness, Paul Durrington, et al.Pharmacogenetics|February 4, 2003
Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheepBharti Mackness, Paul Durrington, Andrew Povey, et al.Circulation|April 2, 2003
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosisAnn Mertens, Peter Verhamme, John K Bielicki, et al.Pageof 7